Interneuron transplants for hard-to-control epilepsy
Cortical Interneuron Transplantation to Treat Intractable Epilepsy
This project develops lab-grown human interneurons to be placed into the brain to try to reduce seizures in adults whose epilepsy does not respond to medicines.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11190390 on NIH RePORTER |
What this research studies
From a patient's view, researchers are creating specialized brain cells from human stem cells that act like the brain's natural inhibitory interneurons and preparing them so they are safe and ready for transplant. They have identified the best stage of cell development to encourage the new neurons to migrate, connect, and work with existing brain circuits without forming tumors. Much of the work tests these cells in models of epilepsy to study where the cells go, how they integrate, and whether they reduce seizures and related behavioral problems. The team is building the preclinical safety and production steps needed to move this approach closer to possible human use.
Who could benefit from this research
Good fit: Ideal candidates would be adults (21+) with medically intractable epilepsy who continue to have seizures despite anti-seizure medications and are seeking advanced treatment options.
Not a fit: People whose seizures are well-controlled by medications or who are not candidates for brain-directed therapies would likely not benefit from this approach.
Why it matters
Potential benefit: If successful, this approach could provide a long-lasting biological therapy that reduces or prevents seizures for people with drug-resistant epilepsy.
How similar studies have performed: Previous animal studies of MGE-type interneuron transplants have reduced seizures and improved behavior in mice, but clinical use in humans remains experimental and unproven.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Chung, Sangmi — Rutgers Biomedical and Health Sciences
- Study coordinator: Chung, Sangmi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.